Organised by:

SUA

Supported by:

SSO

 

Gold Sponsors:





Silver Sponsors:






Bronze Sponsor:




Sponsors:



Lunch Sponsor:

 
 
Day 1
28th February 2008, Thursday
Urofair RCC Symposium
Time Programme
9.00am Opening Address
9.10am UAA Lecture
Update on new treatments and clinical trials for RCC in Asia -
Dr Masaru Murai, M. D.,
The International Goodwill Hospital, Japan
9.30am

Imaging for RCC                                                                     

  • Update on Imaging of the Renal Mass (u/s v ct v mri v pet) - Dr Gan Yu Unn, Asia Healthpartners
  • Imaging in the Era of Anti-Angiogenics - Dr Albert Low, Singapore Gerenal Hospital
  • Imaging Following Partial Nephrectomy - Dr Koh Dow Mu, The London Clinic, UK
10.30am Tea Break
11.00am Management of RCC I
  • Management of the Small Renal Mass - Dr Howard LAU, Westmead Private Hospital, Australia
  • Radiofrequency Ablation for Renal Tumours - Dr Peter GOH, Medi-Rad Associates Ltd, Singapore
  • Lap Nephrectomy / Partial Nephrectomy: The Limits of Lap - Dr Howard LAU, Westmead Private Hospital, Australia
  • Optimising Adjuvant Strategies for High Risk Disease - Dr Christopher WOOD, The University of Texas M.D. Anderson Cancer Centre, USA
12.30pm Management of RCC II
Dr Christopher WOOD, The University of Texas M.D. Anderson Cancer Centre, USA
  • Outcomes in Locally Advanced Disease
  • The Biology of LN Metastases in RCC
  • Cytoreductive Nephrectomy for Metastatic RCC in the Era of Targeted Therapies
1.30pm

Lunch: Bayer Sponsored Symposium – Nexavar (Sorafenib) in RCC
Dr Alvin WONG, National University Hospital, Singapore

2.30pm Update of Pathology of RCC
Prof TAN Puay Hoon, Singapore General Hospital
3.00pm

Basic Science
Animal models for targeted therapies in non-ccRC
Dr Christopher WOOD, The University of Texas M.D. Anderson Cancer Centre, USA  

TGF beta signaling in RCC
Dr Christopher WOOD, The University of Texas M.D. Anderson Cancer Centre, USA

Genetics of RCC including VHL syndrome -
Dr TAN Min Han, National Cancer Centre, Singapore

Molecular markers in RCC -
Dr TAN Min Han, National Cancer Centre, Singapore

4.00pm

Tea Break
Updates on the Management of Advanced RCC (Supported by an Education Grant from Pfizer)

4.30pm

Keynote Lecture
Prognostic Indices for Advanced RCC
Dr Robert J. MOTZER, MD, Memorial Sloan-Kettering Cancer Center, USA

5.15pm Sunitinib & Temsirolimus
Dr Robert J. MOTZER, MD, Memorial Sloan-Kettering Cancer Center, USA
6.00pm

Cocktails and Faculty             

6.30pm Algorithm for the Management of Advanced RCC
Dr Robert J. MOTZER, MD, Memorial Sloan-Kettering Cancer Center, USA
7.00pm Case Discussion (Panel)
8.00pm Dinner
 

 

Day 2
29th February 2008, Friday

  Programme
8.00am Breakfast: GlaxoSmithKline Sponsored Symposium:
The Natural History of BPH: How to Follow-up & Who is At Risk?
Dr Claus ROEHRBORN, Southwestern Medical School, USA
8.45am The Role of UDS in LUTS
Dr Philip E.V. Van KERREBROECK, University Hospital of Masstricht, The Netherlands
9.15am The Evaluation of LUTS: The Local Experience
Dr FOO Keong Tatt, Singapore General Hospital, Singapore
9.45am Tea Break
10.15am Update on Pharmaco-therapy for BPH
Dr Claus ROEHRBORN, Southwestern Medical School, USA
11.00am Update on Minimally Invasive Surgery for BPH
Dr David CONSIGLIERE, National University Hospital, Singapore
11.30am

Podium Presentation (SUA Sanofi-Aventis Prize)  
12.30pm Lunch: Bayer Sponsored Symposium
The Triad of Testosterone Deficiency Syndrome, Erectile Dysfunction and Metabolic Syndrome
Dr Peter LIM, Gleneagles Hospital, Singapore
1.15pm Andrology and the Aging Male
  • Testoterone Replace and Prostate Cancer - Dr Peter Lim, Gleneagles Hospital, Singapore
  • Hormones and the Aging Male - Dr Richard CHEN, Changi General Hospital, Singapore
  • Update on Premature Ejaculation – Dr Lim Kok Bin, Singapore General Hospital
2.15pm Tea Break / Poster Presentation (SUA Sanofi-Aventis Prize)
3.45pm Continence and the Overactive Bladder
  • OAB: Diagnosis and Guidelines - Dr Philip E.V. Van KERREBROECK, University Hospital of Masstricht, The Netherlands
  • Management of Nocturia - Dr Philip E.V. Van KERREBROECK, University Hospital of Masstricht, The Netherlands
  • Botulinum Toxin Therapy: Indications, Pros and Cons - Dr TOH Khai Lee, Tan Tock Seng Hospital, Singapore
  • Stress Incontinence in Women: Current Options - Dr CHIN Chong Min, Chin Chong Min Urology, Singapore
5.00pm
 End
  *programme is subjected to changes without prior notice